Posted by ABMN Staff on Jul 20th, 2024
Equities research analysts at StockNews.com assumed coverage on shares of Invitae (NYSE:NVTA – Get Free Report) in a report issued on Saturday. The firm set a “hold” rating on the medical research company’s stock.
Invitae Stock Performance
Shares of NVTA stock opened at $0.00 on Friday. Invitae has a fifty-two week low of $0.02 and a fifty-two week high of $0.02. The company has a market capitalization of $80,103.00, a PE ratio of 0.00 and a beta of 1.59.
Hedge Funds Weigh In On Invitae
A number of institutional investors have recently bought and sold shares of the stock. SG Americas Securities LLC grew its stake in Invitae by 90.7% in the fourth quarter. SG Americas Securities LLC now owns 91,937 shares of the medical research company’s stock worth $58,000 after purchasing an additional 43,717 shares during the period. Bourne Lent Asset Management Inc. lifted its position in Invitae by 53.3% during the fourth quarter. Bourne Lent Asset Management Inc. now owns 574,600 shares of the medical research company’s stock valued at $360,000 after buying an additional 199,900 shares during the period. Prosperity Wealth Management Inc. bought a new stake in shares of Invitae during the 4th quarter valued at $144,000. Finally, Vestmark Advisory Solutions Inc. purchased a new stake in shares of Invitae in the 4th quarter worth about $526,000. 61.28% of the stock is owned by institutional investors.
About Invitae
Invitae Corporation, a medical genetics company, that provides genetic information to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, precision oncology, women’s health, rare diseases, and pharmacogenomics; digital health solutions; and health data services.
See Also
- Five stocks we like better than Invitae
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Is This Telehealth Stock a Buy After the Recent Pullback?
- What Makes a Stock a Good Dividend Stock?
- Safeguard Against Credit Card Risks with This Top Financial Stock
- Where to Find Earnings Call Transcripts
- Streaming Titan’s Stock Ready to Hit All-Time Highs This Year
Receive News & Ratings for Invitae Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Invitae and related companies with MarketBeat.com’s FREE daily email newsletter.
You might be interested in:
